Skip to main content

Table 1 A describes the in silico qRT-PCR kit validation with SARS-CoV-2 Delta variant and B describes the in silico qRT-PCR kit validation with SARS-CoV-2 Omicron variant

From: A two-step process for in silico screening to assess the performance of qRTPCR kits against variant strains of SARS-CoV-2

A

In silico evaluation of qRT-PCR Kits with SARS-CoV-2 Delta Variant

 

Alignment results with global Delta sequences (First level screening analysis)

Alignment results with Indian Delta sequences (Second level screening analysis)

Overall resultsa

Type of Kit

Total number of kits

No. satisfactory

% satisfactory

No. of kits

No. satisfactory

% satisfactory

Overall satisfactory %

One gene

3

2

67

0

NA

NA

67

Two gene

53

39

74

1

1

100

75

Three gene

16

13

81

2

0

0

81

Four gene

1

1

100

0

NA

NA

100

Total

73

55

75

3

1

33

77

B

In silico evaluation of qRT-PCR Kits with SARS-CoV-2 Omicron Variant

 

Alignment results with global Omicron sequences (First level screening analysis)

Alignment results with Indian Omicron sequences (Second level screening analysis)

Overall resultsa

Type of Kit

Total number of kits

No. satisfactory

% satisfactory

No. of kits

No. satisfactory

% satisfactory

Overall satisfactory %

One gene

3

1

33

2

1

50

67

Two gene

53

34

64

16

12

75

87

Three gene

16

13

81

2

2

100

94

Four gene

1

1

100

0

NA

NA

100

Total

73

49

67

20

15

75

88

  1. aThe overall results were calculated by adding the number of satisfactory kits in first and second level screening then divided by total number of kits in each category and expressed as percentage